Top Story

Morning Read: Turing Pharmaceuticals will lower Daraprim’s price

Turing Pharmaceuticals and Martin Shkreli blink (maybe), Anthem-Aetna Capitol Hill testimony begins, and Nestle gets deeper into the medical research.

TOP STORIES

Maybe the last words – at least for awhile – on Martin Shkreli and Turing Pharmaceuticals?

  • Turing will drop the price of Daraprim in the coming weeks. To what? He would not say. – CNBC
  • Shkreli is “a sponge for information” but “there’s nobody there in Martin’s life to tell him what the right thing is.” – The New York Times
  • Shkreli may be the whipping boy for critics of soaring drug prices, but don’t blame pharmaceutical companies, author Rafi Mohammed argued. Some price regulation may be in order, he said. — Harvard Business Review
  • BMO Capital remains bullish on Valeant Pharmaceuticals, despite that company being called out by Hillary Clinton for “price gouging.” — Bidness Etc

LIFE SCIENCE

The Mylan-Perrigo bids are now deep in the courts. Mylan  has countersued to correct “serious misstatements.”- Reuters

presented by

Nestle has struck a collaboration deal with AC Immune to develop an Alzheimer’s test, underscoring “the commitment by the world’s largest packaged food company to the faster-growing, more profitable medical field as sales of processed foods slow in many markets.” – Reuters

Bridge Bank has launched a life science group to provide debt to pharma, medical device and biotech. – Marketwired

A research team at McGill University in Montreal is making strides in understanding the progression of Parkinson’s disease. — ScienceDaily

PAYERS-PROVIDERS

Save this quote from the Anthem-Aetna hearings: “Our savings will be passed along in the pricing of our product.” –FierceHealthPayer

On the day that the Institute of Medicine released a landmark report on diagnostic error, CNN provides this clickbait, er, slideshow of “25 shocking medical mistakes.” — CNN

The former owner of a long-shuttered Chicago hospital pleaded guilty to perjury, following years of denying Medicare fraud, multimillion-dollar civil judgments and an extradition battle. — Chicago Tribune

The former King/Drew Medical Center in Los Angeles, a.k.a. “Killer King,” is putting the emphasis on care teams and patient safety under new management and a new name. — Los Angeles Times

Researchers at Cincinnati Children’s Hospital Medical Center have discovered a new type of cell that could provide clues to food allergies. — PR Newswire

TECH

A wearable for athletes (aren’t they all?) named Whoop has raised $12 million. – MobiHealthNews

Here’s a list of healthcare CIO budget priorities – EMR & HIPAA

Medical students named fragmented care the top safety risk for patients, according to an Epocrates survey, suggesting that interoperability of health data should be a priority. — athenahealth

Clearwater Clinical has formed a mobile endoscopy and mobile medical photography division called Modica. — Clearwater Clinical

POLITICS

Health and Human Service is already lower expectation for the next round of health-law signups, saying it could be “the toughest yet.” – Wall Street Journal

A whistleblower with a group called “VA Truth Tellers” told a congressional panel that the Department of Veterans Affairs’ Office of Inspector General is “a joke.” — Associated Press via U.S. News & World Report

New York allowed people to get health insurance benefits they weren’t supposed to. – Wall Street Journal

CGI Federal received $4 million in taxpayer money to clean up the healthcare.gov mess it was responsible for. — Bloomberg

A LITTLE EXTRA

PETA is suing to assign ownership of “Monkey Selfies” to the monkey that took the pics. No, really. — Reuters via Yahoo!

Photo: Flickr user Damian Gadal